$0.00 $0.00 (0.0%)

12:00 AM EST on 01/01/01

Savara Inc Com (NYSEMKT:MSTX)

CAPS Rating: No stars

A biopharmaceutical research and development company focused on commercializing proprietary product candidates for the treatment of cancer and infectious diseases.

Current Price $0.00 Mkt Cap $0.00
Open $0.00 P/E Ratio 0.00
Prev. Close $0.00 Div. (Yield) $0.00 (0.0%)
Daily Range $0.00 - $0.00 Volume
52-Wk Range $0.00 - $0.00 Avg. Daily Vol.

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

90 Outperform
10 Underperform
 

All-Star Players

6 Outperform
1 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSEMKT:MSTX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

wsantan (< 20)
Submitted July 10, 2011

The stock will outperform the market because of the FDA approval date set for Sept 1st, people are going to be pumping it up throughout August.

zzlangerhans (99.60)
Submitted April 08, 2014

This is a risky red thumb, because in the current volatile biopharma environment almost any dubious outfit can become a multibagger in a fortnight if the right people suddenly take an interest in making it one. On the other hand, I think it's more… More

NYSEMKT:MSTX VS S&P 500 (SPY)

Fools bullish on NYSEMKT:MSTX are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about MSTX.

Recs

0
Member Avatar union9193 (< 20) Submitted: 10/8/2014 8:27:46 PM : Outperform Start Price: $0.58 NYSE MKT:MSTX Score: -146.04

Currently under valued.

Recs

0
Member Avatar asilverp (21.65) Submitted: 8/27/2014 11:55:58 PM : Outperform Start Price: $0.61 NYSE MKT:MSTX Score: -144.22

I have to agree with Buffetjunior, it seems hard to argue with the risk/reward of a company with no debt, cash on hand, assets on the books and low share price in an industry that is potentially transformative.

Recs

0
Member Avatar DanishDynamite (< 20) Submitted: 7/22/2011 4:36:53 AM : Outperform Start Price: $3.58 NYSE MKT:MSTX Score: -242.71

Build-up and spike on FDA decision

Leaderboard

Find the members with the highest scoring picks in MSTX.

Score Leader

smallandmidcap

smallandmidcap (94.54) Score: +289.06

The Score Leader is the player with the highest score across all their picks in MSTX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
smallandmidcap 94.54 8/10/2010 Underperform 5Y $2.03 -93.55% +195.82% +289.37 0 Comment
longtermgrowth09 34.55 8/3/2010 Underperform 5Y $2.13 -93.85% +194.64% +288.49 0 Comment
decembermeter 31.14 12/6/2010 Underperform 5Y $2.47 -94.70% +170.25% +264.95 0 Comment
brandonprice1973 25.94 10/25/2011 Underperform 5Y $1.10 -88.09% +166.62% +254.71 0 Comment
4x4ing 64.59 10/19/2006 Underperform 3W $2.72 -95.18% +158.07% +253.25 0 Comment
3acrerock 72.31 1/3/2007 Underperform 1Y $2.84 -95.39% +145.84% +241.23 0 Comment
ramhigh < 20 2/8/2007 Underperform 3W $2.50 -94.76% +142.68% +237.44 0 Comment
IdahoInvestor 32.97 5/30/2012 Underperform 5Y $0.53 -75.28% +151.51% +226.79 0 Comment
crowke < 20 6/29/2007 Underperform 3M $2.54 -94.84% +130.89% +225.73 0 Comment
ECWTully369 < 20 9/17/2012 Underperform 3M $0.69 -81.01% +125.30% +206.31 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for MSTX.